Medical device recalls Moderate risk

Hyphen BioMed recalls ZYMUTEST HIA MonoStrip IgGAM. Model Number: RK041D. Qualitative screening assay for the detection of heparin-dependent…

Recall date
November 9, 2011
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1063-2018
FDA classification
Class II
Brand / firm
Hyphen BioMed
Sold / distributed
Worldwide Distribution - US Distribution and to the countries of : Austria and France.

Why it was recalled

A voluntary recall is initiated for ZYMUTEST HIA lgGAM - Ref RK040D - Lot F1700415 and ZYMUTEST HIA MonoStrip lgGAM - Ref RK041D - Lot F1700416 because they may produce false positive results.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

ZYMUTEST HIA MonoStrip IgGAM. Model Number: RK041D. Qualitative screening assay for the detection of heparin-dependent antibodies (IgG, IgM and IgA isotypes by ELISA. 32 Tests.

Get recall alerts

Free email alert whenever Hyphen BioMed has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Hyphen BioMed